Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective, Non-Randomized, Open-Label, Multi-Center, Single Arm Study of Exchange of Travoprost Intraocular Implant

Next Previous
X
Search
Trial Profile

Prospective, Non-Randomized, Open-Label, Multi-Center, Single Arm Study of Exchange of Travoprost Intraocular Implant

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 28 Sep 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Travoprost (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Adverse reactions; Registrational
  • Sponsors Glaukos Corporation

    • Most Recent Events

    • 27 Jun 2023 Status changed from active, no longer recruiting to completed.
    • 10 Jan 2023 According to a Glaukos Corporation media release, A total of 33 subjects were enrolled and 32 subjects (97.0%) completed the trial.
    • 10 Jan 2023 According to a Glaukos Corporation media release, positive data from this trial will be included in the upcoming U.S. Food and Drug Administration (FDA) New Drug Application (NDA) submission targeted for the first quarter of 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top